Skip to content
value.today

Occulo Holdings LLC

🇺🇸 Lebanon, New Hampshire, USABiotechnologyFounded 2016
Total raised
$13 M
1 round on record
Latest round
$13 M
Oct 2017
First round on record
Oct 2017
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Occulo Holdings LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2017$13 MNo. 1$10 to $50 million

Occulo Holdings LLC: Raise no. 1, Oct 2017

Investors in this round

2 investors had bought by the notice of Nov 17, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Chris Bailey-Kellogg · Executive Officer, Director
  • Karl Griswold · Executive Officer, Director
  • Xiuyan Xu · Director
  • Yong Wang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than ordinary course executive compensation for such persons.”

Signed by Karl E. Griswold, Chief Executive Officer. Newest notice filed Nov 17, 2017. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Occulo Holdings LLC chose not to state its revenue in its newest notice of a funding round (Nov 2017).

    SEC Form D · Nov 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2017

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Occulo Holdings LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Occulo Holdings LLC
NameRoleNamed in
Chris Bailey-KelloggExecutive officerNov 2017
Karl GriswoldExecutive officerNov 2017
Chris Bailey-KelloggDirectorNov 2017
Karl GriswoldDirectorNov 2017
Xiuyan XuDirectorNov 2017
Yong WangDirectorNov 2017